Global Liver Biopsy 麻豆原创 Research Report 2023

Publication ID:

PB502233350

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.
Highlights
The global Liver Biopsy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Liver biopsies may be taken percutaneously (via a needle through the skin), transvenously (through the blood vessels), endoscopically (through endoscopic ultrasound fine needle biopsy), or directly during abdominal surgery. The sample is examined by microscope, and may be processed further by immunohistochemistry, determination of iron and copper content, and microbiological culture if tuberculosis is suspected.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Biopsy.
The Liver Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liver Biopsy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems
Segment by Type
Percutaneous
Transjugular
Laparoscopic
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Biopsy companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Liver Biopsy 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Percutaneous
1.2.3 Transjugular
1.2.4 Laparoscopic
1.3 麻豆原创 by Application
1.3.1 Global Liver Biopsy 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Biopsy 麻豆原创 Perspective (2018-2029)
2.2 Liver Biopsy Growth Trends by Region
2.2.1 Global Liver Biopsy 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liver Biopsy Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Liver Biopsy Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Liver Biopsy 麻豆原创 Dynamics
2.3.1 Liver Biopsy Industry Trends
2.3.2 Liver Biopsy 麻豆原创 Drivers
2.3.3 Liver Biopsy 麻豆原创 Challenges
2.3.4 Liver Biopsy 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Biopsy Players by Revenue
3.1.1 Global Top Liver Biopsy Players by Revenue (2018-2023)
3.1.2 Global Liver Biopsy Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Liver Biopsy 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Biopsy Revenue
3.4 Global Liver Biopsy 麻豆原创 Concentration Ratio
3.4.1 Global Liver Biopsy 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Biopsy Revenue in 2022
3.5 Liver Biopsy Key Players Head office and Area Served
3.6 Key Players Liver Biopsy Product Solution and Service
3.7 Date of Enter into Liver Biopsy 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Biopsy Breakdown Data by Type
4.1 Global Liver Biopsy Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Liver Biopsy Forecasted 麻豆原创 Size by Type (2024-2029)
5 Liver Biopsy Breakdown Data by Application
5.1 Global Liver Biopsy Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Liver Biopsy Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Liver Biopsy 麻豆原创 Size (2018-2029)
6.2 North America Liver Biopsy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Liver Biopsy 麻豆原创 Size by Country (2018-2023)
6.4 North America Liver Biopsy 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Biopsy 麻豆原创 Size (2018-2029)
7.2 Europe Liver Biopsy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Liver Biopsy 麻豆原创 Size by Country (2018-2023)
7.4 Europe Liver Biopsy 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Biopsy 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Liver Biopsy 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Liver Biopsy 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Liver Biopsy 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Biopsy 麻豆原创 Size (2018-2029)
9.2 Latin America Liver Biopsy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Liver Biopsy 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Liver Biopsy 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Biopsy 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Liver Biopsy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Liver Biopsy 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Liver Biopsy 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cook Medical
11.1.1 Cook Medical Company Detail
11.1.2 Cook Medical Business Overview
11.1.3 Cook Medical Liver Biopsy Introduction
11.1.4 Cook Medical Revenue in Liver Biopsy Business (2018-2023)
11.1.5 Cook Medical Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Liver Biopsy Introduction
11.2.4 Boston Scientific Revenue in Liver Biopsy Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Liver Biopsy Introduction
11.3.4 Hologic Revenue in Liver Biopsy Business (2018-2023)
11.3.5 Hologic Recent Development
11.4 MDxHealth
11.4.1 MDxHealth Company Detail
11.4.2 MDxHealth Business Overview
11.4.3 MDxHealth Liver Biopsy Introduction
11.4.4 MDxHealth Revenue in Liver Biopsy Business (2018-2023)
11.4.5 MDxHealth Recent Development
11.5 CR Bard
11.5.1 CR Bard Company Detail
11.5.2 CR Bard Business Overview
11.5.3 CR Bard Liver Biopsy Introduction
11.5.4 CR Bard Revenue in Liver Biopsy Business (2018-2023)
11.5.5 CR Bard Recent Development
11.6 Intact Medical
11.6.1 Intact Medical Company Detail
11.6.2 Intact Medical Business Overview
11.6.3 Intact Medical Liver Biopsy Introduction
11.6.4 Intact Medical Revenue in Liver Biopsy Business (2018-2023)
11.6.5 Intact Medical Recent Development
11.7 Veran Medical
11.7.1 Veran Medical Company Detail
11.7.2 Veran Medical Business Overview
11.7.3 Veran Medical Liver Biopsy Introduction
11.7.4 Veran Medical Revenue in Liver Biopsy Business (2018-2023)
11.7.5 Veran Medical Recent Development
11.8 Leica Biosystems
11.8.1 Leica Biosystems Company Detail
11.8.2 Leica Biosystems Business Overview
11.8.3 Leica Biosystems Liver Biopsy Introduction
11.8.4 Leica Biosystems Revenue in Liver Biopsy Business (2018-2023)
11.8.5 Leica Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.